About CannaPharmaRX
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company primarily negotiates, acquires, and develops various cannabis cultivation projects. The company is also looking at possible opportunities in the U.S.
As of December 31, 2020, the company’s activities centered around three projects, including the Hanover Project, the Great Northern Project, and the acquisition of Sunniva Medical, Inc. (SMI); and the development of a cannabis cultivation facility.
Country
Industry:
Founded:
1998
IPO Date:
10/29/1999
ISIN Number:
I_US13765D1090
Contact Details
Address:
888 3rd Street SW, Suite 3600, Calgary, Alberta, T2P 5C5, Canada
Phone Number
949-652-6838
Key Executives
CEO:
Medwid, Dean
CFO
Foeste, Oliver
COO:
Data Unavailable